Bristol-Myers Squibb Co news

   Watch this stock
Showing stories 1 - 10 of about 193   

Articles published

BMY 61.32 -0.54 (-0.87%)
price chart
Industry Group Rank Limit Bristol-Myers Squibb Co (BMY) Rating
The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) has been derived by using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator.
Bristol-Myers Squibb shares decline 2% on Q3 profit miss, revenue beat ...
Bristol-Myers Squibb Co. BMY, +1.31% shares declined 1.9% in premarket trade Thursday after the company reported a third-quarter profit miss and revenue beat and changed its 2017 guidance.
Bristol-Myers Squibb Co. Reports 8% Decline In Q3 Bottom Line  Nasdaq
Bristol-Myers Squibb Co (BMY) Stock Falls on Earnings Miss  Investorplace.com
Biocon arm widens partnership terms with Bristol-Myers Squibb
"The next phase of the partnership will see the addition of a new facility to support future Bristol-Myers Squibb research and development operations, an expansion of the team and the extension of the existing agreement through 2026," Syngene ...
Guyasuta Investment Advisors Lifted Bristol Myers Squibb Co (BMY) Holding by ...  BZ Weekly
Bristol-Myers Squibb Company (BMY) Position Increased by Hartland & Co. LLC  Week Herald
Bristol-Myers Squibb Co (BMY) Ranking Raised to Buy on Superior Earnings ...
Bristol-Myers Squibb Co (NYSE:BMY) is a constituent of the 135 company Pharmaceuticals GICS industry group, which is part of the 783 company GICS Health Care sector.
Sessa Capital Im LP Cut Its Bristol Myers Squibb Co (Call) (BMY) Stake as ...  WeeklyHub
Rating for Bristol-Myers Squibb Co (BMY) Drops….. Wilting Earnings Visibility
The current recommendation of Hold for Bristol-Myers Squibb Co (NYSE:BMY) is the result of using the Portfolio Grader stock evaluator of Louis Navellier, which incorporates his investing system.
Madrona Financial Services, LLC Buys ONEOK Inc, Boeing Co, Bristol-Myers ...  Nasdaq
Bristol-Myers Squibb Co (NYSE:BMY) Poised to Boost as Acid Test at 1.5  Morning Outlook
Nippon Life Insurance Co. Has $4.52 Million Stake in Bristol-Myers Squibb ...
Bristol-Myers Squibb logo Nippon Life Insurance Co. trimmed its position in shares of Bristol-Myers Squibb Company (NYSE:BMY) by 2.0% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission.
Arrow Financial Trimmed Bristol Myers Squibb Co (BMY) Position By $870540 ...  Wolcott Daily
Bristol-Myers Squibb Company (BMY) Position Increased by Geode Capital ...  Newburgh Gazette
Bristol-Myers Squibb's Valuations after Its 3Q17 Earnings
On October 31, 2017, Bristol-Myers Squibb (BMY) traded at a forward PE multiple of ~18.9x, compared to the industry average of 13.9x.
Bristol Myers Squibb Co (NYSE:BMY) Q2 2017 Sentiment  WeeklyHub
Nippon Life Insurance Co. Sells 1655 Shares of Bristol-Myers Squibb Company ...  Dispatch Tribunal
As Bristol Myers Squibb Co (BMY) Valuation Declined, Wellington Management ...
Investors sentiment decreased to 0.95 in 2017 Q2. Its down 0.03, from 0.98 in 2017Q1. It worsened, as 78 investors sold BMY shares while 520 reduced holdings.
Bristol-Myers Squibb (BMY) Presents at Jefferies 2017 London Healthcare ...  Seeking Alpha
Short Term Outlook For Bristol-Myers Squibb Company (NYSE:BMY)  Gears Of Biz
Bristol Myers Squibb Co (BMY) Market Valuation Declined While Umb Bank NA ...
Investors sentiment decreased to 0.95 in Q2 2017. Its down 0.03, from 0.98 in 2017Q1. It turned negative, as 78 investors sold BMY shares while 520 reduced holdings.
Which Will Pfizer Buy? Biogen or Bristol-Myers Squibb
Biogen or Bristol-Myers Squibb. By. Johanna Bennett. Nov. 13, 2017 10:08 a.m. ET. Text Size; Regular; Medium; Large. Everyone has heard the talk.